Remifentanil Hydrochloride
盐酸瑞芬太尼
Report date: 2023/02/27 20:00:18
NME
Base Information
Drug NameRemifentanil Hydrochloride
Drug Alias Name +[13]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[17]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory +[12]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbott Laboratories
China Registration ClassN/A
Develop Information
Active CompaniesJohnson & Johnson Innovative MedicineUniversity Of California San FranciscoUniversity of California Irvine +[7]
Inactive CompaniesGlaxosmithkline PlcImam Abdulrahman Bin Faisal UniversityAjou University School Of Medicine +[13]
Active Indications +[4]
Inactive Indications +[13]